A Series of Briefs from the 2024 ECTRIMS Conference The European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) conference is the world’s largest gathering focused on advancements in…
Read More
Proposed Changes to How We Determine Who Has MS At the ECTRIMS meeting in September, there was a presentation on proposed updates to the 2017 McDonald criteria to diagnose MS….
New Medical Director on What’s Next in MS InforMS Magazine is excited to welcome the Rocky Mountain MS Center’s new Medical Director, Dr. Enrique Alvarez. While the title may be…
A new class of treatment approaches for MS being studied are Bruton’s Tyrosine Kinase (BTK) inhibitors, or BTKi. Designed as once-daily oral enzyme inhibitors, BTK inhibitors target specific immune cells…
Our immune system is a vast and powerful network, filled with specialized cells and proteins designed to protect us from infections and diseases. However, in autoimmune diseases like MS, some…
Research is the driver of progress in MS care and treatment. In this issue, we’ll take you inside some of the most promising innovations transforming the MS landscape. We begin…
